Apyx Medical Corp (APYX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
APYX currently has 43.7M outstanding shares. with moderate dilution risk from 19M authorized shares representing 43.4% potential dilution. The company has diluted shareholders by 24.53% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 43.7M shares outstanding |
44M | 19M |
| Mar 10, 2026 |
10-K filing | 41.1M shares outstanding |
41M | 22M |
| Dec 01, 2025 |
S-3 filing: This S-3 filing indicates APYX MEDICAL CORPORATION intends to offer and sell up to $100,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants, and/or units. |
41M | 22M |
| Nov 06, 2025 |
10-Q filing | 40.7M shares outstanding |
41M | 22M |
| Aug 07, 2025 |
10-Q filing | 40.7M shares outstanding |
41M | 22M |
| May 08, 2025 |
10-Q filing | 40.7M shares outstanding |
41M | 22M |
| Mar 13, 2025 |
10-K filing | 35.5M shares outstanding |
36M | 27M |
| Nov 08, 2024 |
10-Q filing | 34.6M shares outstanding |
35M | 28M |
| Nov 08, 2024 |
8-K filing: Apyx Medical Corporation entered into Amendment No. 1 to its Credit Agreement and Guaranty, and also closed a registered direct offering of common stock and pre-funded warrants, generating approximately $7 million in gross proceeds. ($7.0M proceeds) |
35M | 28M |
| Aug 08, 2024 |
10-Q filing | 34.6M shares outstanding |
35M | 28M |
| May 09, 2024 |
10-Q filing | 34.6M shares outstanding |
35M | 28M |
| Mar 21, 2024 |
10-K filing | 34.6M shares outstanding |
35M | 28M |
| Nov 09, 2023 |
8-K filing: Apyx Medical Corporation entered into a Credit and Guaranty Agreement with Perceptive Credit Holdings IV, LP for up to $45 million, issuing warrants to purchase up to 1,250,000 shares of common stock at $2.43 per share in connection with the initial loan. |
35M | 28M |
| Nov 09, 2023 |
10-Q filing | 34.6M shares outstanding |
35M | 28M |
| Aug 11, 2023 |
10-Q filing | 34.6M shares outstanding |
35M | 28M |
| May 11, 2023 |
10-Q filing | 34.6M shares outstanding |
35M | 28M |
| Mar 16, 2023 |
10-K filing | 34.5M shares outstanding |
35M | 28M |
| Feb 24, 2023 |
8-K filing: Apyx Medical Corporation entered into a Credit, Security and Guaranty Agreement providing for an up to $35 million facility and issued warrants to purchase up to 250,000 shares of its common stock to a statutory trust of MidCap Financial. |
35M | 28M |
| Dec 02, 2022 |
S-3/A filing: This S-3/A filing relates to an at-the-market offering of common stock with an aggregate offering price of up to $40,000,000. The offering may be made from time to time through the agent, Piper Sandler. The company intends to use the net proceeds for working capital and other general corporate purposes. |
35M | 28M |
| Nov 22, 2022 |
S-3 filing: This is an S-3 filing for an at-the-market offering of common stock with an aggregate offering price of up to $40,000,000. The offering may be made from time to time through the agent, Piper Sandler. |
35M | 28M |
| Nov 10, 2022 |
10-Q filing | 34.6M shares outstanding |
35M | 0 |
| Aug 11, 2022 |
10-Q filing | 34.5M shares outstanding |
34M | 0 |
| May 12, 2022 |
10-Q filing | 34.4M shares outstanding |
34M | 0 |
| Mar 17, 2022 |
10-K filing | 34.3M shares outstanding |
34M | 0 |
| Nov 12, 2021 |
10-Q filing | 34.3M shares outstanding |
34M | 0 |
| Aug 12, 2021 |
10-Q filing | 34.3M shares outstanding |
34M | 0 |
| May 12, 2021 |
10-Q filing | 34.3M shares outstanding |
34M | 0 |
| Mar 31, 2021 |
10-K filing | 34.3M shares outstanding |
34M | 0 |
| Nov 09, 2020 |
10-Q filing | 34.3M shares outstanding |
34M | 0 |
| Aug 10, 2020 |
10-Q filing | 34.2M shares outstanding |
34M | 0 |
| May 11, 2020 |
10-Q filing | 34.2M shares outstanding |
34M | 0 |
| Mar 31, 2020 |
10-K filing | 31.4M shares outstanding |
31M | 0 |